Menopause Drugs Market Insights, Global Outlook and Forecast 2022-2028
Menopause Drugs Market Insights, Global Outlook and Forecast 2022-2028
The report classifies the business vertical into various segments based on components, voltage, end-user scope, and regional division. A thorough analysis of each segment with respect to their market share, growth rate, and revenue contribution forms a major part of the study.
Exclusive deal : 20% Instant discount on Direct purchases! Don't wait—claim your discount today!
Menopause is the end of a woman’s menstrual cycles. The term can describe any of the changes you go through just before or after you stop having your period, marking the end of your reproductive years.
The latest research study released by Market IntelliX evaluates market size and forecasts of Menopause Drugs in global, including the following market information:
Global Menopause Drugs Market Revenue, 2017-2022, 2023-2028, ($ millions)
Global Menopause Drugs Market Sales, 2017-2022, 2023-2028, (K Units)
Global top five Menopause Drugs companies in 2021 (%)
The global Menopause Drugs market was valued at million in 2021 and is projected to reach US$ million by 2028, at a CAGR of % during the forecast period.
The U.S. Market is Estimated at $ Million in 2021, While China is Forecast to Reach $ Million by 2028.
Parenteral Segment to Reach $ Million by 2028, with a % CAGR in next six years.
The global key manufacturers of Menopause Drugs include Eli Lilly, Pfizer, AbbVie, Novo Nordisk, Merck KGaA, Mylan, Bayer, Teva and Novartis, etc. In 2021, the global top five players have a share approximately % in terms of revenue.
MI has surveyed the Menopause Drugs manufacturers, suppliers, distributors and industry experts on this industry, involving the sales, revenue, demand, price change, product type, recent development and plan, industry trends, drivers, challenges, obstacles, and potential risks.
Market Segmentations:
Global Menopause Drugs Market, by Type, 2017-2022, 2023-2028 ($ Millions) & (K Units)
Global Menopause Drugs Market Segment Percentages, by Type, 2021 (%)
Parenteral
Transdermal
Oral
Others
Global Menopause Drugs Market, by Application, 2017-2022, 2023-2028 ($ Millions) & (K Units)
Global Menopause Drugs Market Segment Percentages, by Application, 2021 (%)
Hospitals
Drugstores
Others
Global Menopause Drugs Market, By Region and Country, 2017-2022, 2023-2028 ($ Millions) & (K Units)
Global Menopause Drugs Market Segment Percentages, By Region and Country, 2021 (%)
North America
US
Canada
Mexico
Europe
Germany
France
U.K.
Italy
Russia
Nordic Countries
Benelux
Rest of Europe
Asia
China
Japan
South Korea
Southeast Asia
India
Rest of Asia
South America
Brazil
Argentina
Rest of South America
Middle East & Africa
Turkey
Israel
Saudi Arabia
UAE
Rest of Middle East & Africa
Competitor Analysis
The report also provides analysis of leading market participants including:
Key companies Menopause Drugs revenues in global market, 2017-2022 (Estimated), ($ millions)
Key companies Menopause Drugs revenues share in global market, 2021 (%)
Key companies Menopause Drugs sales in global market, 2017-2022 (Estimated), (K Units)
Key companies Menopause Drugs sales share in global market, 2021 (%)
The report presents profiles of competitors in the market, Some of the prominent key players covered:
Eli Lilly
Pfizer
AbbVie
Novo Nordisk
Merck KGaA
Mylan
Bayer
Teva
Novartis
Abbott
Roche
Endo International
Ipsen
ANI Pharmaceuticals
TherapeuticsMD
Key Takeaways from this Report
Evaluate market potential through analyzing growth rates (CAGR %), Volume (Units) and Value ($M) data given at country level – for product types, end use applications and by different industry verticals.
Understand the different dynamics influencing the market – key driving factors, challenges and hidden opportunities.
Get in-depth insights on your competitor performance – market shares, strategies, financial benchmarking, product benchmarking, SWOT and more.
Analyze the sales and distribution channels across key geographies to improve top-line revenues.
Understand the industry supply chain with a deep-dive on the value augmentation at each step, in order to optimize value and bring efficiencies in your processes.
Get a quick outlook on the market entropy – M&A’s, deals, partnerships, product launches of all key players for the past 4 years.
Evaluate the supply-demand gaps, import-export statistics and regulatory landscape for more than top 20 countries globally for the market.
1 Introduction to Research & Analysis Reports
1.1 Menopause Drugs Market Definition
1.2 Market Segments
1.2.1 Market by Type
1.2.2 Market by Application
1.3 Global Menopause Drugs Market Overview
1.4 Features & Benefits of This Report
1.5 Methodology & Sources of Information
1.5.1 Research Methodology
1.5.2 Research Process
1.5.3 Base Year
1.5.4 Report Assumptions & Caveats
2 Global Menopause Drugs Overall Market Size
2.1 Global Menopause Drugs Market Size: 2021 VS 2028
2.2 Global Menopause Drugs Revenue, Prospects & Forecasts: 2017-2028
2.3 Global Menopause Drugs Sales: 2017-2028
3 Company Landscape
3.1 Top Menopause Drugs Players in Global Market
3.2 Top Global Menopause Drugs Companies Ranked by Revenue
3.3 Global Menopause Drugs Revenue by Companies
3.4 Global Menopause Drugs Sales by Companies
3.5 Global Menopause Drugs Price by Manufacturer (2017-2022)
3.6 Top 3 and Top 5 Menopause Drugs Companies in Global Market, by Revenue in 2021
3.7 Global Manufacturers Menopause Drugs Product Type
3.8 Tier 1, Tier 2 and Tier 3 Menopause Drugs Players in Global Market
3.8.1 List of Global Tier 1 Menopause Drugs Companies
3.8.2 List of Global Tier 2 and Tier 3 Menopause Drugs Companies
4 Sights by Product
4.1 Overview
4.1.1 By Type - Global Menopause Drugs Market Size Markets, 2021 & 2028
4.1.2 Parenteral
4.1.3 Transdermal
4.1.4 Oral
4.1.5 Others
4.2 By Type - Global Menopause Drugs Revenue & Forecasts
4.2.1 By Type - Global Menopause Drugs Revenue, 2017-2022
4.2.2 By Type - Global Menopause Drugs Revenue, 2023-2028
4.2.3 By Type - Global Menopause Drugs Revenue Market Share, 2017-2028
4.3 By Type - Global Menopause Drugs Sales & Forecasts
4.3.1 By Type - Global Menopause Drugs Sales, 2017-2022
4.3.2 By Type - Global Menopause Drugs Sales, 2023-2028
4.3.3 By Type - Global Menopause Drugs Sales Market Share, 2017-2028
4.4 By Type - Global Menopause Drugs Price (Manufacturers Selling Prices), 2017-2028
5 Sights By Application
5.1 Overview
5.1.1 By Application - Global Menopause Drugs Market Size, 2021 & 2028
5.1.2 Hospitals
5.1.3 Drugstores
5.1.4 Others
5.2 By Application - Global Menopause Drugs Revenue & Forecasts
5.2.1 By Application - Global Menopause Drugs Revenue, 2017-2022
5.2.2 By Application - Global Menopause Drugs Revenue, 2023-2028
5.2.3 By Application - Global Menopause Drugs Revenue Market Share, 2017-2028
5.3 By Application - Global Menopause Drugs Sales & Forecasts
5.3.1 By Application - Global Menopause Drugs Sales, 2017-2022
5.3.2 By Application - Global Menopause Drugs Sales, 2023-2028
5.3.3 By Application - Global Menopause Drugs Sales Market Share, 2017-2028
5.4 By Application - Global Menopause Drugs Price (Manufacturers Selling Prices), 2017-2028
6 Sights by Region
6.1 By Region - Global Menopause Drugs Market Size, 2021 & 2028
6.2 By Region - Global Menopause Drugs Revenue & Forecasts
6.2.1 By Region - Global Menopause Drugs Revenue, 2017-2022
6.2.2 By Region - Global Menopause Drugs Revenue, 2023-2028
6.2.3 By Region - Global Menopause Drugs Revenue Market Share, 2017-2028
6.3 By Region - Global Menopause Drugs Sales & Forecasts
6.3.1 By Region - Global Menopause Drugs Sales, 2017-2022
6.3.2 By Region - Global Menopause Drugs Sales, 2023-2028
6.3.3 By Region - Global Menopause Drugs Sales Market Share, 2017-2028
6.4 North America
6.4.1 By Country - North America Menopause Drugs Revenue, 2017-2028
6.4.2 By Country - North America Menopause Drugs Sales, 2017-2028
6.4.3 US Menopause Drugs Market Size, 2017-2028
6.4.4 Canada Menopause Drugs Market Size, 2017-2028
6.4.5 Mexico Menopause Drugs Market Size, 2017-2028
6.5 Europe
6.5.1 By Country - Europe Menopause Drugs Revenue, 2017-2028
6.5.2 By Country - Europe Menopause Drugs Sales, 2017-2028
6.5.3 Germany Menopause Drugs Market Size, 2017-2028
6.5.4 France Menopause Drugs Market Size, 2017-2028
6.5.5 U.K. Menopause Drugs Market Size, 2017-2028
6.5.6 Italy Menopause Drugs Market Size, 2017-2028
6.5.7 Russia Menopause Drugs Market Size, 2017-2028
6.5.8 Nordic Countries Menopause Drugs Market Size, 2017-2028
6.5.9 Benelux Menopause Drugs Market Size, 2017-2028
6.6 Asia
6.6.1 By Region - Asia Menopause Drugs Revenue, 2017-2028
6.6.2 By Region - Asia Menopause Drugs Sales, 2017-2028
6.6.3 China Menopause Drugs Market Size, 2017-2028
6.6.4 Japan Menopause Drugs Market Size, 2017-2028
6.6.5 South Korea Menopause Drugs Market Size, 2017-2028
6.6.6 Southeast Asia Menopause Drugs Market Size, 2017-2028
6.6.7 India Menopause Drugs Market Size, 2017-2028
6.7 South America
6.7.1 By Country - South America Menopause Drugs Revenue, 2017-2028
6.7.2 By Country - South America Menopause Drugs Sales, 2017-2028
6.7.3 Brazil Menopause Drugs Market Size, 2017-2028
6.7.4 Argentina Menopause Drugs Market Size, 2017-2028
6.8 Middle East & Africa
6.8.1 By Country - Middle East & Africa Menopause Drugs Revenue, 2017-2028
6.8.2 By Country - Middle East & Africa Menopause Drugs Sales, 2017-2028
6.8.3 Turkey Menopause Drugs Market Size, 2017-2028
6.8.4 Israel Menopause Drugs Market Size, 2017-2028
6.8.5 Saudi Arabia Menopause Drugs Market Size, 2017-2028
6.8.6 UAE Menopause Drugs Market Size, 2017-2028
7 Manufacturers & Brands Profiles
7.1 Eli Lilly
7.1.1 Eli Lilly Corporate Summary
7.1.2 Eli Lilly Business Overview
7.1.3 Eli Lilly Menopause Drugs Major Product Offerings
7.1.4 Eli Lilly Menopause Drugs Sales and Revenue in Global (2017-2022)
7.1.5 Eli Lilly Key News
7.2 Pfizer
7.2.1 Pfizer Corporate Summary
7.2.2 Pfizer Business Overview
7.2.3 Pfizer Menopause Drugs Major Product Offerings
7.2.4 Pfizer Menopause Drugs Sales and Revenue in Global (2017-2022)
7.2.5 Pfizer Key News
7.3 AbbVie
7.3.1 AbbVie Corporate Summary
7.3.2 AbbVie Business Overview
7.3.3 AbbVie Menopause Drugs Major Product Offerings
7.3.4 AbbVie Menopause Drugs Sales and Revenue in Global (2017-2022)
7.3.5 AbbVie Key News
7.4 Novo Nordisk
7.4.1 Novo Nordisk Corporate Summary
7.4.2 Novo Nordisk Business Overview
7.4.3 Novo Nordisk Menopause Drugs Major Product Offerings
7.4.4 Novo Nordisk Menopause Drugs Sales and Revenue in Global (2017-2022)
7.4.5 Novo Nordisk Key News
7.5 Merck KGaA
7.5.1 Merck KGaA Corporate Summary
7.5.2 Merck KGaA Business Overview
7.5.3 Merck KGaA Menopause Drugs Major Product Offerings
7.5.4 Merck KGaA Menopause Drugs Sales and Revenue in Global (2017-2022)
7.5.5 Merck KGaA Key News
7.6 Mylan
7.6.1 Mylan Corporate Summary
7.6.2 Mylan Business Overview
7.6.3 Mylan Menopause Drugs Major Product Offerings
7.6.4 Mylan Menopause Drugs Sales and Revenue in Global (2017-2022)
7.6.5 Mylan Key News
7.7 Bayer
7.7.1 Bayer Corporate Summary
7.7.2 Bayer Business Overview
7.7.3 Bayer Menopause Drugs Major Product Offerings
7.7.4 Bayer Menopause Drugs Sales and Revenue in Global (2017-2022)
7.7.5 Bayer Key News
7.8 Teva
7.8.1 Teva Corporate Summary
7.8.2 Teva Business Overview
7.8.3 Teva Menopause Drugs Major Product Offerings
7.8.4 Teva Menopause Drugs Sales and Revenue in Global (2017-2022)
7.8.5 Teva Key News
7.9 Novartis
7.9.1 Novartis Corporate Summary
7.9.2 Novartis Business Overview
7.9.3 Novartis Menopause Drugs Major Product Offerings
7.9.4 Novartis Menopause Drugs Sales and Revenue in Global (2017-2022)
7.9.5 Novartis Key News
7.10 Abbott
7.10.1 Abbott Corporate Summary
7.10.2 Abbott Business Overview
7.10.3 Abbott Menopause Drugs Major Product Offerings
7.10.4 Abbott Menopause Drugs Sales and Revenue in Global (2017-2022)
7.10.5 Abbott Key News
7.11 Roche
7.11.1 Roche Corporate Summary
7.11.2 Roche Menopause Drugs Business Overview
7.11.3 Roche Menopause Drugs Major Product Offerings
7.11.4 Roche Menopause Drugs Sales and Revenue in Global (2017-2022)
7.11.5 Roche Key News
7.12 Endo International
7.12.1 Endo International Corporate Summary
7.12.2 Endo International Menopause Drugs Business Overview
7.12.3 Endo International Menopause Drugs Major Product Offerings
7.12.4 Endo International Menopause Drugs Sales and Revenue in Global (2017-2022)
7.12.5 Endo International Key News
7.13 Ipsen
7.13.1 Ipsen Corporate Summary
7.13.2 Ipsen Menopause Drugs Business Overview
7.13.3 Ipsen Menopause Drugs Major Product Offerings
7.13.4 Ipsen Menopause Drugs Sales and Revenue in Global (2017-2022)
7.13.5 Ipsen Key News
7.14 ANI Pharmaceuticals
7.14.1 ANI Pharmaceuticals Corporate Summary
7.14.2 ANI Pharmaceuticals Business Overview
7.14.3 ANI Pharmaceuticals Menopause Drugs Major Product Offerings
7.14.4 ANI Pharmaceuticals Menopause Drugs Sales and Revenue in Global (2017-2022)
7.14.5 ANI Pharmaceuticals Key News
7.15 TherapeuticsMD
7.15.1 TherapeuticsMD Corporate Summary
7.15.2 TherapeuticsMD Business Overview
7.15.3 TherapeuticsMD Menopause Drugs Major Product Offerings
7.15.4 TherapeuticsMD Menopause Drugs Sales and Revenue in Global (2017-2022)
7.15.5 TherapeuticsMD Key News
8 Global Menopause Drugs Production Capacity, Analysis
8.1 Global Menopause Drugs Production Capacity, 2017-2028
8.2 Menopause Drugs Production Capacity of Key Manufacturers in Global Market
8.3 Global Menopause Drugs Production by Region
9 Key Market Trends, Opportunity, Drivers and Restraints
9.1 Market Opportunities & Trends
9.2 Market Drivers
9.3 Market Restraints
10 Menopause Drugs Supply Chain Analysis
10.1 Menopause Drugs Industry Value Chain
10.2 Menopause Drugs Upstream Market
10.3 Menopause Drugs Downstream and Clients
10.4 Marketing Channels Analysis
10.4.1 Marketing Channels
10.4.2 Menopause Drugs Distributors and Sales Agents in Global
11 Conclusion
12 Appendix
12.1 Note
12.2 Examples of Clients
12.3 Disclaimer
Research Methodology:
Menopause Drugs Market Size Estimation
To estimate market size and trends, we use a combination of top-down and bottom-up methods. This allows us to evaluate the market from various perspectives—by company, region, product type, and end users.
Our estimates are based on actual sales data, excluding any discounts. Segment breakdowns and market shares are calculated using weighted averages based on usage rates and average prices. Regional insights are determined by how widely a product or service is adopted in each area.
Key companies are identified through secondary sources like industry reports and company filings. We then verify revenue estimates and other key data points through primary research, including interviews with industry experts, company executives, and decision-makers.
We take into account all relevant factors that could influence the market and validate our findings with real-world input. Our final insights combine both qualitative and quantitative data to provide a well-rounded view. Please note, these estimates do not account for unexpected changes such as inflation, economic downturns, or policy shifts.
Data Source
Secondary Sources
This study draws on a wide range of secondary sources, including press releases, annual reports, non-profit organizations, industry associations, government agencies, and customs data. We also referred to reputable databases and directories such as Bloomberg, Wind Info, Hoovers, Factiva, Trading Economics, Statista, and others. Additional references include investor presentations, company filings (e.g., SEC), economic data, and documents from regulatory and industry bodies.
These sources were used to gather technical and market-focused insights, identify key players, analyze market segmentation and classification, and track major trends and developments across industries.
| Market Size |
|
|
| Market Position of Top Company |
|
|
| Qualitative Analysis |
|
|
Primary Sources
As part of our primary research, we interviewed a variety of stakeholders from both the supply and demand sides to gather valuable qualitative and quantitative insights.
On the supply side, we spoke with product manufacturers, competitors, industry experts, research institutions, distributors, traders, and raw material suppliers. On the demand side, we engaged with business leaders, marketing and sales heads, technology and innovation directors, supply chain executives, and end users across key organizations.
These conversations helped us better understand market segmentation, pricing, applications, leading players, supply chains, demand trends, industry outlook, and key market dynamics—including risks, opportunities, barriers, and strategic developments.
Key Data Information from Primary Sources
| Primary Sources | Parameters | Key Data |
| Market Segments(by Application, by Type) |
|
|
| Total Market |
|
|